Can a simple ultrasound score spot ovarian cancer?
NCT ID NCT07289126
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will check if an ultrasound scoring system called O-RADS can accurately tell benign from cancerous ovarian masses. About 80 women aged 18 to 70 with ovarian cysts or masses will get standard care, including detailed ultrasound and, if needed, surgery. Researchers will compare the O-RADS score to the final tissue diagnosis to see how well it works.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better identify which ovarian masses are cancerous using ultrasound, potentially reducing unnecessary surgeries.
- What could go wrong
- This is a small, early observational study, not a treatment trial. The scoring system may not be accurate enough to replace current methods, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Women aged 18 to 70 years attending the Women's Health Hospital, Assiut University, with ovarian cysts or masses detected on routine transabdominal or transvaginal ultrasound will be invited to participate. Eligible patients will undergo standardized clinical assessment, ultrasound evaluation using the O-RADS system, MRI when clinically indicated, and subsequent surgical exploration and histopathological examination or follow-up according to usual care. Patients with prior ovarian surgery for the same lesion, pregnancy, functional ovarian cysts, or those who decline consent or are lost before histopathological confirmation will be excluded.
- Ages
-
18 to 70 years
- Sex
-
Female participants only
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Any female patient with ovarian cyst or mass during routine trans-abdominal or pelvic US * Age between 18 and 70 years. Exclusion Criteria: * Refusal of patients to filling consent. * Patient with a previous history of the operated ovarian lesion * Patient missed during follow-up or not provided pathology report. * Pregnancy. * Patients with functional ovarian masses ( e.g functional cysts )
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Ovarian mass are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.